Skip to content

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

비즈헬스

[비즈헬스] Celltrion’s corona 19 treatment’Rekironaju’ approval is imminent…  Opinion that approval is possible under the premise of Phase 3

[비즈헬스] Celltrion’s corona 19 treatment’Rekironaju’ approval is imminent… Opinion that approval is possible under the premise of Phase 3

[비즈헬스] “Easily prevent corona”…  Hanmi Pharm vs. Daewoong Pharm develops respiratory blocker and pill-type oral drug for nose

[비즈헬스] “Easily prevent corona”… Hanmi Pharm vs. Daewoong Pharm develops respiratory blocker and pill-type oral drug for nose

[비즈헬스] “Manageable from scalp to pain”…  ‘Micro current’ attracting new attention

[비즈헬스] “Manageable from scalp to pain”… ‘Micro current’ attracting new attention

[비즈헬스] “Manageable from scalp to pain”…  ‘Micro current’ attracting new attention

[비즈헬스] “Manageable from scalp to pain”… ‘Micro current’ attracting new attention

footer

  • Contact Us
  • Sitemap
  • News-Sitemap
© 2025 Aju.News/en